A detailed history of Raymond James & Associates transactions in Establishment Labs Holdings Inc. stock. As of the latest transaction made, Raymond James & Associates holds 4,546 shares of ESTA stock, worth $200,933. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,546
Holding current value
$200,933
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$41.46 - $59.86 $188,477 - $272,123
4,546 New
4,546 $206,000
Q4 2022

Feb 08, 2023

SELL
$51.0 - $72.94 $4,743 - $6,783
-93 Reduced 2.14%
4,250 $279,000
Q1 2022

May 11, 2022

BUY
$48.73 - $69.9 $4,531 - $6,500
93 Added 2.19%
4,343 $293,000
Q4 2021

Feb 08, 2022

SELL
$59.19 - $81.54 $1,420 - $1,956
-24 Reduced 0.56%
4,250 $287,000
Q3 2021

Nov 02, 2021

BUY
$65.48 - $88.21 $1,571 - $2,117
24 Added 0.56%
4,274 $306,000
Q1 2021

May 14, 2021

BUY
$36.0 - $73.76 $153,000 - $313,480
4,250 New
4,250 $266,000

Others Institutions Holding ESTA

About ESTABLISHMENT LABS HOLDINGS INC.


  • Ticker ESTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,268,500
  • Market Cap $1.07B
  • Description
  • Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone...
More about ESTA
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.